"None of this applies to people with FAP or non-polyposis colorectal cancer syndromes or very high colon cancer risk based on family history, " Ladabaum says.
Celebrex has been approved for preventing the formation of potentially cancerous polyps in FAP, or familial adenomatus polyposis, a familial disease that causes them to form more frequently.